Cardinal Health (CAH) Tops Q1 EPS by 3c; Lowers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Leerink Partners Cuts Price Target on Cardinal Health (CAH) Following 1Q
November 1, 2016 7:53 AM EDTLeerink Partners maintained an Outperform rating on Cardinal Health (NYSE: CAH), and cut the price target to $80.00 (from $95.00), following the company's 1Q earnings report. Leerink cut EPS estimates for 2017 and 2018 by ~$0.15 and ~$0.20, respectively, due to the headwinds in the Pharmaceutical Division. On the call management stated that in 2Q the... More
